跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEMAZIN KIDS 2+ COUGH + IMMUNE DEFENCE Oral liquid - TGA Drug Approval Details
Approvals
/
TGA
/
DEMAZIN KIDS 2+ COUGH + IMMUNE DEFENCE Oral liquid
Approved
STANDARD
DEMAZIN KIDS 2+ COUGH + IMMUNE DEFENCE Oral liquid
iNova Pharmaceuticals (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
2ae18ed86fe74568
Company
iNova Pharmaceuticals (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
2ae18ed86fe74568
Product Name
DEMAZIN KIDS 2+ COUGH + IMMUNE DEFENCE Oral liquid
Artg Id
326835
Artg Name
DEMAZIN KIDS 2+ COUGH + IMMUNE DEFENCE Oral liquid
Sponsor
iNova Pharmaceuticals (Australia) Pty Ltd
Company Detail Path
/organization/inova-pharmaceuticals-australia-pty-limited
Artg Date
2019-11-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
2ae18ed86fe74568
Type
Standard
Back to TGA Approvals
